NR 565 FINAL EXAM EXAM QUESTIONS WITH CORRECT VERIFIED ANSWERS | 100% PASS (A+ CERTIFIED)
NR 565 FINAL EXAM EXAM QUESTIONS WITH CORRECT VERIFIED ANSWERS | 100% PASS (A+ CERTIFIED) 1. Acute symptoms of diabetes plus casual plasma glucose concentration greater than or equal to 200 mg/dL. *Casual is defined as any time of day without regard to time since last meal. The classic symptoms of diabetes are polyuria, polydipsia, and unexplained weight loss. a. Pre-diabetes b. Diabetes mellitus b 2. Fasting plasma glucose greater than or equal to 126 mg/dL. *Fasting is defined as no caloric intake for at least 8 hours. a. Diabetes mellitus b. Pre-diabetes a 3. 2 hour post-load plasma glucose in an oral glucose tolerance test greater than or equal to 200 mg/dL. The test uses a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water. a. Pre-diabetes b. Diabetes mellitus b 4. HgbA1c greater than or equal to 6.5% a. Diabetes mellitus b. Pre-diabetes a 5. Fasting plasma glucose 100 to 125 mg/dL (IFG) or a. Diabetes mellitus b. Pre-diabetes b 6. Plasma glucose 140 to 199 mg/dL (IGT) 2 hours post ingestion of standard glucose load (75 g) or a. Diabetes mellitus b. Pre-diabetes b 7. HgbA1c 5.7% to 6.4% a. Diabetes mellitus b. Pre-diabetes b 8. SGLT2i (sodium-glucose cotransporter-2 inhibitors) ozin 9. Biguanides Metformin (Glucophage) 10. DPP-4i (Dipeptidyl Peptidase-4 Inhibitors) - iptin 11. Sulfonylureas - Gly or Gli 12. GLP-1 (Glucagon-like peptide 1 receptor agonists) - glutides 13. TZD (Thiazolidinediones) - azone 14. Rapid onset insulin aspart (Novolog), glulisine (apidra) and lispro (humalog) 15. Rapid acting onset 5-30 minutes 16. rapid acting peak 0.5 - 3 hours 17. rapid acting duration 3-4 hours 18. short acting insulin Regular (Humulin R, Novolin R) 19. short acting onset 30-60 min 20. short acting peak 2-4 h 21. short acting duration 3-7 h 22. intermediate acting insulin Isophane (NPH) 23. intermediate acting onset 1-2 hours 24. intermediate acting peak 4-10 hours 25. intermediate acting duration 10-16 h 26. long acting insulin glargine (Lantus) detemir (Levemir) 27. long acting onset 1-2 hours 28. long acting peak none 29. long acting duration 20-24 h 30. fixed combination insulin NPH mixed with regular or lisper or aspirate 31. fixed combination onset 5-60 minutes 32. fixed combination peak dual 33. fixed combination duration 16 h 34. TSH is low, free T4 is high and T3 is normal Etiology can be related to exogenous T4 ingestion, a concurrent non thyroidal illness, or amiodarone-induced thyroid dysfunction. 35. Serum TSH is normal or elevated, and free T4 and T3 are elevated Possibility of a TSH producing pituitary tumor, which would need to be evaluated further with magnetic resonance imaging. 36. TSH is low, the free T4 is normal and the serum T3 is high Primary hyperthyroidism. However, other reasons for this thyroid function test abnormality could be exogenous T3 ingestion, or a functioning adenoma. 37. Which of the following agents is the first-line treatment for hyperthyroidism or Grave's disease? a. Metoprolol b. Methimazole c. Allopurinol d. Levothyroxine b 38. Which of the following agents is the preferred treatment option for thyroid storm? a. Iodine-131 b. Methylphenidate c. Levothyroxine d. PTU d 39. Which laboratory tests should be completed before prescribing methimazole? Select all that apply. a. thyroid-stimulating hormone (TSH) b. CMP c. free thyroxine (T4) d. free triiodothyronine (T3) e. CBC f. LFTs a, c, d, e, f
Written for
- Institution
- NR 565
- Course
- NR 565
Document information
- Uploaded on
- November 12, 2025
- Number of pages
- 14
- Written in
- 2025/2026
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
nr 565 final exam
-
final exam questions
-
exam questions with correct verified answers
-
answers 100 pass a certified